Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Cheng currently holds 436,837 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Cheng has been a net seller of AKRO stock. They have purchased $0 and sold $26.8M worth of shares.
Andrew Cheng's most recent insider trade was on Dec 9, 2025, when they sold 277,075 shares at $0.00 per share.
Andrew Cheng serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 140 insider transactions totaling $26.8M over their tenure at the company.
Andrew Cheng holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andrew Cheng has shown a selling trading pattern, with $0 in total purchases and $26.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew Cheng was on Oct 10, 2025, when they sold $1.6M worth of AKRO shares. This transaction involved 30,000 shares at $53.98 per share.
Andrew Cheng currently owns 436,837 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Cheng's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Cheng has 140 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Andrew Cheng and 40,000+ other insiders.